{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Gout+Attack", "query": { "condition": "Gout Attack" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 39, "total_pages": 4, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Gout+Attack&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-05-22T06:44:07.108Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00506883", "title": "MPC-004 for the Treatment of an Acute Gout Flare", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Gout" ], "interventions": [ { "name": "High Dose Colchicine (4.8 mg total dose)", "type": "DRUG" }, { "name": "Low Dose Colchicine (1.8mg total dose)", "type": "DRUG" }, { "name": "Placebo Control", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Takeda", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 185, "start_date": "2007-04", "completion_date": "2007-10", "has_results": true, "last_update_posted_date": "2012-11-01", "last_synced_at": "2026-05-22T06:44:07.108Z", "location_count": 83, "location_summary": "Birmingham, Alabama • Columbiana, Alabama • Huntsville, Alabama + 78 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Columbiana", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT00506883" }, { "nct_id": "NCT01356602", "title": "Safety and Efficacy of Canakinumab Prefilled Syringes in Frequently Flaring Acute Gouty Arthritis Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Acute Gouty Arthritis" ], "interventions": [ { "name": "Canakinumab pre-filled syringe", "type": "DRUG" }, { "name": "Canakinumab lyophilized powder", "type": "DRUG" }, { "name": "Triamcinolone Acetonide", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 397, "start_date": "2011-05", "completion_date": "2012-09", "has_results": true, "last_update_posted_date": "2014-01-29", "last_synced_at": "2026-05-22T06:44:07.108Z", "location_count": 69, "location_summary": "Anniston, Alabama • Gulf Shores, Alabama • Mobile, Alabama + 62 more", "locations": [ { "city": "Anniston", "state": "Alabama" }, { "city": "Gulf Shores", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Chandler", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT01356602" }, { "nct_id": "NCT00549549", "title": "Celebrex In Acute Gouty Arthritis Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Arthritis, Gouty" ], "interventions": [ { "name": "Indomethacin", "type": "DRUG" }, { "name": "Celecoxib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer's Upjohn has merged with Mylan to form Viatris Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 402, "start_date": "2008-02", "completion_date": "2009-12", "has_results": true, "last_update_posted_date": "2021-02-21", "last_synced_at": "2026-05-22T06:44:07.108Z", "location_count": 43, "location_summary": "Glendale, Arizona • Mesa, Arizona • Paradise Valley, Arizona + 37 more", "locations": [ { "city": "Glendale", "state": "Arizona" }, { "city": "Mesa", "state": "Arizona" }, { "city": "Paradise Valley", "state": "Arizona" }, { "city": "Peoria", "state": "Arizona" }, { "city": "Roseville", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00549549" }, { "nct_id": "NCT01101035", "title": "Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Cardiovascular Disease" ], "interventions": [ { "name": "Febuxostat", "type": "DRUG" }, { "name": "Allopurinol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Takeda", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 6198, "start_date": "2010-04-23", "completion_date": "2017-07-18", "has_results": true, "last_update_posted_date": "2018-06-14", "last_synced_at": "2026-05-22T06:44:07.108Z", "location_count": 202, "location_summary": "Decatur, Georgia • Dunwoody, Georgia • Marietta, Georgia + 199 more", "locations": [ { "city": "Decatur", "state": "Georgia" }, { "city": "Dunwoody", "state": "Georgia" }, { "city": "Marietta", "state": "Georgia" }, { "city": "Norcross", "state": "Georgia" }, { "city": "Roswell", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT01101035" }, { "nct_id": "NCT01018420", "title": "Pharmacokinetic and Exploratory Electrocardiogram (ECG) Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Pharmacokinetics" ], "interventions": [ { "name": "Colchicine", "type": "DRUG" }, { "name": "Moxifloxacin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mutual Pharmaceutical Company, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 18, "start_date": "2007-11", "completion_date": "2008-01", "has_results": true, "last_update_posted_date": "2009-12-01", "last_synced_at": "2026-05-22T06:44:07.108Z", "location_count": 1, "location_summary": "Fargo, North Dakota", "locations": [ { "city": "Fargo", "state": "North Dakota" } ], "official_url": "https://clinicaltrials.gov/study/NCT01018420" }, { "nct_id": "NCT04849312", "title": "Prediction of 30-Day Readmission Using Machine Learning", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Infection", "Heart Failure", "Chronic Obstructive Pulmonary Disease", "Asthma", "Gout Flare", "Chronic Kidney Diseases", "Hypertensive Urgency", "Atrial Fibrillation Rapid", "Anticoagulants; Increased" ], "interventions": [], "intervention_types": [], "sponsor": "Brigham and Women's Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 372, "start_date": "2017-06-01", "completion_date": "2019-11-30", "has_results": false, "last_update_posted_date": "2026-03-17", "last_synced_at": "2026-05-22T06:44:07.108Z", "location_count": 2, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT04849312" }, { "nct_id": "NCT03636373", "title": "Pilot Study Evaluating The Efficacy Of Etanercept In Acute Gout", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Gout Attack" ], "interventions": [ { "name": "Etanercept", "type": "DRUG" }, { "name": "Triamcinolone Acetonide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Rutgers, The State University of New Jersey", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 5, "start_date": "2019-10-25", "completion_date": "2021-08-13", "has_results": true, "last_update_posted_date": "2023-10-27", "last_synced_at": "2026-05-22T06:44:07.108Z", "location_count": 1, "location_summary": "New Brunswick, New Jersey", "locations": [ { "city": "New Brunswick", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT03636373" }, { "nct_id": "NCT05045742", "title": "Prediction of Patient Deterioration Using Machine Learning", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Infection", "Heart Failure", "Chronic Obstructive Pulmonary Disease", "Asthma", "Gout Flare", "Chronic Kidney Diseases", "Hypertensive Urgency", "Atrial Fibrillation Rapid", "Anticoagulants; Increased" ], "interventions": [ { "name": "Traditional vital sign alarms versus the BioVitals Index vs the National Early Warning Score 2", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Brigham and Women's Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 526, "start_date": "2021-03-20", "completion_date": "2026-02-16", "has_results": false, "last_update_posted_date": "2026-03-17", "last_synced_at": "2026-05-22T06:44:07.108Z", "location_count": 2, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT05045742" }, { "nct_id": "NCT05256303", "title": "Rural Hospital-Level Care at Home for Acutely Ill Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Infections", "Heart Failure", "Chronic Obstructive Pulmonary Disease", "Asthma", "Gout Flare", "Chronic Kidney Diseases", "Hypertensive Urgency", "Atrial Fibrillation Rapid", "Anticoagulation", "Diabetes and Its Complications", "End of Life/Desires Only Medical Management" ], "interventions": [ { "name": "Home Hospital care", "type": "OTHER" }, { "name": "Traditional Hospital care", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Brigham and Women's Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 160, "start_date": "2022-02-16", "completion_date": "2024-01-17", "has_results": false, "last_update_posted_date": "2025-11-12", "last_synced_at": "2026-05-22T06:44:07.108Z", "location_count": 2, "location_summary": "Quincy, Illinois • Hazard, Kentucky", "locations": [ { "city": "Quincy", "state": "Illinois" }, { "city": "Hazard", "state": "Kentucky" } ], "official_url": "https://clinicaltrials.gov/study/NCT05256303" }, { "nct_id": "NCT01080131", "title": "Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicines Including a 12 Week Extension and a 1 Year Open-label Extension Study.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Acute Gout" ], "interventions": [ { "name": "Canakinumab 150 mg", "type": "DRUG" }, { "name": "Triamcinolone acetonide 40 mg", "type": "DRUG" }, { "name": "Placebo to canakinumab", "type": "DRUG" }, { "name": "Placebo to triamcinolone acetonide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 226, "start_date": "2010-03", "completion_date": "2011-10", "has_results": true, "last_update_posted_date": "2014-01-30", "last_synced_at": "2026-05-22T06:44:07.108Z", "location_count": 96, "location_summary": "Anniston, Alabama • Birmingham, Alabama • Foley, Alabama + 81 more", "locations": [ { "city": "Anniston", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Foley", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Peoria", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT01080131" } ] }